Cancer-­‐Associated Thrombosis and Vascular Dysfunction: From Molecular to Large Data Bases

1230 – 1240p Welcome & Opening remarks by Katya Ravid, DSc, Director, ECIBR, IBRO and a faculty member of the Cardiovascular Institute, and Julie Palmer, ScD, Director, Cancer Center) 1245 – 115p Nigel Mackman, PhD, Distinguished Professor of Medicine, Director of the UNC McAllister Heart Institute, “Mouse models of cancer-­‐associated thrombosis and vascular dysfunction” 130 – 200p Keith McCrae, MD, Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, “Extracellular vesicles in cancer-­‐associated thrombosis” 210 – 230p Coffee Break 230 – 300p Natalie Artzi, PhD, Assistant Professor, Brigham and Women’s Hospital, Harvard Medical School, Principal Research Scientist, MIT, and Associate Member, Broad Institute of Harvard and MIT, “Bioengineering approaches to therapy: cancer and cancer-­‐associated vascular changes” 315 – 345p Christopher O’Donnell, MD, Associate Professor of Medicine, Boston VA Healthcare System, Cardiology Section, “The VA data base as a resource for predictive biomarkers” 400 – 415p Vipul Chitalia, MD, PhD, Associate Professor of Medicine, BUSM, will present brief highlights of Thrombosis ARC collaborative discoveries and Closing Remarks; The Thrombosis ARC is led by Drs. Vipul Chitalia, Jean Francis and Katya Ravid 415 – 500p Post-­‐docs & Faculty Networking over Wine & Cheese Reception The event is organized by the Evans Center for IBR (ECIBR; www.bumc.bu.edu/evanscenteribr/) & BU Interdisciplinary Biomedical Research Office (IBRO; www.bu.edu/research/ibro), and hosted in collaboration with BUMC Cancer Center, the CTSI, Boston VA Healthcare and Massachusetts Academy of Sciences (MAS; www.maacadsci.org).